18
CASE SUMMARY: A 61-year-old woman with no apparent risk factors for liver injury developed acute hepatitis one week after the final dose of a long-term course of pulse itraconazole therapy (200 mg orally twice daily, 1 wk on, 3 wk off, for 24 wk) for onychomycosis.
 A 61-year-old woman with no apparent risk factors for liver injury: Subject; 61-year-old: Subject.Age; woman: Subject.Gender; acute hepatitis: Effect; long-term course of pulse itraconazole therapy (200 mg orally twice daily, 1 wk on, 3 wk off, for 24 wk): Treatment; onychomycosis: Treatment.Disorder; itraconazole: Treatment.Drug; 200 mg: Treatment.Dosage; orally: Treatment.Route; twice daily: Treatment.Freq
Given event type and trigger, please tell me the arguments of all the listed option. Output format is "name1: role1; name2: role2". 
Event type: adverse event 
  Option: Treatment.Freq, Subject.Population, Combination.Drug, Subject.Gender, Treatment.Duration, Subject, Effect, Treatment, Treatment.Disorder, Subject.Disorder, Treatment.Route, Subject.Race, Treatment.Time_elapsed, Treatment.Dosage, Subject.Age, Treatment.Drug 
Text: {0} 
Answer:
 A 61-year-old woman with no apparent risk factors for liver injury: Subject; 61-year-old: Subject.Age; woman: Subject.Gender; acute hepatitis: Effect; long-term course of pulse itraconazole therapy (200 mg orally twice daily, 1 wk on, 3 wk off, for 24 wk): Treatment; onychomycosis: Treatment.Disorder; itraconazole: Treatment.Drug; 200 mg: Treatment.Dosage; orally: Treatment.Route; twice daily: Treatment.Freq